These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 9562977)
1. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Arbiser JL; Fine JD; Murrell D; Paller A; Connors S; Keough K; Marsh E; Folkman J Mol Med; 1998 Mar; 4(3):191-5. PubMed ID: 9562977 [TBL] [Abstract][Full Text] [Related]
2. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Kim M; Murrell DF Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672 [TBL] [Abstract][Full Text] [Related]
3. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952 [TBL] [Abstract][Full Text] [Related]
4. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report. Gayathri E; Anbukkarasi K; Lilly SM Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084 [TBL] [Abstract][Full Text] [Related]
5. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Ng YZ; Pourreyron C; Salas-Alanis JC; Dayal JH; Cepeda-Valdes R; Yan W; Wright S; Chen M; Fine JD; Hogg FJ; McGrath JA; Murrell DF; Leigh IM; Lane EB; South AP Cancer Res; 2012 Jul; 72(14):3522-34. PubMed ID: 22564523 [TBL] [Abstract][Full Text] [Related]
7. Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa. Rami A; Łaczmański Ł; Jacków-Nowicka J; Jacków J Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383666 [TBL] [Abstract][Full Text] [Related]
8. Age and etiology of childhood epidermolysis bullosa mortality. Hon KL; Li JJ; Cheng BL; Luk DC; Murrell DF; Choi PC; Leung AK J Dermatolog Treat; 2015 Apr; 26(2):178-82. PubMed ID: 24724596 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America. Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139 [TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of the collagenase promoter in recessive dystrophic epidermolysis bullosa fibroblasts: role of endogenously activated AP-1. Unemori EN; Mauch C; Hoeffler W; Kim Y; Amento EP; Bauer EA Exp Cell Res; 1994 Apr; 211(2):212-8. PubMed ID: 8143767 [TBL] [Abstract][Full Text] [Related]